+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Buprenorphine"

Visceral Pain Global Market Report 2024 - Product Thumbnail Image

Visceral Pain Global Market Report 2024

  • Report
  • April 2024
  • 175 Pages
  • Global
From
Addictions Therapeutics Global Market Report 2024 - Product Thumbnail Image

Addictions Therapeutics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Opioid Use Disorder (OUD) Global Market Report 2024 - Product Thumbnail Image

Opioid Use Disorder (OUD) Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Pain Patch Global Market Report 2024 - Product Thumbnail Image

Pain Patch Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Opioids Global Market Report 2024 - Product Thumbnail Image

Opioids Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
From
From
From
Opioid Dependence - Pipeline Insight, 2024 - Product Thumbnail Image

Opioid Dependence - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Opioid related disorder - Pipeline Insight, 2024 - Product Thumbnail Image

Opioid related disorder - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Opioid Withdrawal Syndrome- - Pipeline Insight, 2024 - Product Thumbnail Image

Opioid Withdrawal Syndrome- - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Opioid mu receptor antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

Opioid mu receptor antagonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Nociceptin receptor agonists - Pipeline Insight, 2024 - Product Thumbnail Image

Nociceptin receptor agonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
From
Opioid Use Disorder Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Opioid Use Disorder Market Forecasts from 2023 to 2028

  • Report
  • November 2023
  • 140 Pages
  • Global
From
From
Loading Indicator

Buprenorphine is an analgesic medication used to treat moderate to severe pain. It is a semi-synthetic opioid derived from thebaine, an alkaloid found in the opium poppy. Buprenorphine is available in both immediate-release and extended-release formulations, and is typically administered orally or sublingually. It is commonly used in combination with other analgesics, such as acetaminophen or ibuprofen, to provide more effective pain relief. Buprenorphine is a popular choice for treating chronic pain due to its long-lasting effects and low risk of addiction. It is also used to treat opioid addiction, as it has a lower potential for abuse than other opioids. Buprenorphine is available in generic form, as well as under brand names such as Subutex and Suboxone. Some companies in the buprenorphine market include Reckitt Benckiser, Indivior, Mylan, and Dr. Reddy's Laboratories. Show Less Read more